Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels

PLoS Neglected Tropical Diseases

Volumn 11, Issue 5, 2017, Pages

  Arnold, Benjamin F ^a   van der Laan, Mark J ^a   Hubbard, Alan E ^a   Steel, Cathy ^b   Kubofcik, Joseph ^b   Hamlin, Katy L ^c   Moss, Delynn M ^d   Nutman, Thomas B ^b   Priest, Jeffrey W ^d   Lammie, Patrick J ^c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e Task Force for Global Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DIETHYLCARBAMAZINE; IMMUNOGLOBULIN G; PYRIMETHAMINE; ANTIBODY;

ADULT; AGE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGICAL TECHNIQUE; IMMUNOPRECIPITATION; INOCULATION; LYMPHATIC FILARIASIS; MALARIA; PLASMODIUM FALCIPARUM; SEROPREVALENCE; TROPICAL DISEASE; ADOLESCENT; AGED; ANIMAL; BLOOD; ELEPHANTIASIS, FILARIAL; FEMALE; GASTROINTESTINAL DISEASES; HAITI; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEGLECTED DISEASES; NEWBORN; NIGERIA; POLYNESIA; PRESCHOOL CHILD; PROCEDURES; SEROEPIDEMIOLOGY; SEROLOGY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ELEPHANTIASIS, FILARIAL; FEMALE; GASTROINTESTINAL DISEASES; HAITI; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALE; MIDDLE AGED; NEGLECTED DISEASES; NIGERIA; POLYNESIA; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; UNITED STATES; YOUNG ADULT;

EID: 85020379067     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005616     Document Type: Article

References (55)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357: 1018–1027. doi: 10.1056/NEJMra064142 17804846
2. Lammie PJ, Moss DM, Brook Goodhew E, Hamlin K, Krolewiecki A, West SK, et al. Development of a new platform for neglected tropical disease surveillance. Int J Parasitol. 2012;42: 797–800. doi: 10.1016/j.ijpara.2012.07.002 22846784
3. Corran P, Coleman P, Riley E, Drakeley C, Serology: a robust indicator of malaria transmission intensity?Trends Parasitol. 2007;23: 575–582. doi: 10.1016/j.pt.2007.08.023 17988945
4. Hens N, Shkedy Z, Aerts M, Damme CFPV, Beutels P, Modeling Infectious Disease Parameters Based on Serological and Social Contact Data. Springer; 2012.
5. Rogier E, Wiegand R, Moss D, Priest J, Angov E, Dutta S, et al. Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J. 2015;14: 436. doi: 10.1186/s12936-015-0955-1 26537125
6. Sepúlveda N, Drakeley C, Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J. 2015;14: 141. doi: 10.1186/s12936-015-0661-z 25889960
7. White MT, Griffin JT, Akpogheneta O, Conway DJ, Koram KA, Riley EM, et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. J Infect Dis. 2014;210: 1115–1122. doi: 10.1093/infdis/jiu219 24719471
8. Pothin E, Ferguson NM, Drakeley CJ, Ghani AC, Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models. Malar J. malariajournal.biomedcentral.com; 2016;15: 79. doi: 10.1186/s12936-016-1121-0 26861862
9. Yman V, White MT, Rono J, Arcà B, Osier FH, Troye-Blomberg M, et al. Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep. nature.com; 2016;6: 19472. doi: 10.1038/srep19472 26846726
10. Woolhouse ME, Patterns in parasite epidemiology: the peak shift. Parasitol Today. 1998;14: 428–434. 17040835
11. Woolhouse ME, A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol. 1992;14: 563–578. 1470476
12. Blackwell AD, Gurven MD, Sugiyama LS, Madimenos FC, Liebert MA, Martin MA, et al. Evidence for a peak shift in a humoral response to helminths: age profiles of IgE in the Shuar of Ecuador, the Tsimane of Bolivia, and the U.S. NHANES. PLoS Negl Trop Dis. 2011;5: e1218. doi: 10.1371/journal.pntd.0001218 21738813
13. Zinkernagel RM, Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med. 2001;345: 1331–1335. doi: 10.1056/NEJMra012493 11794153
14. Manz RA, Hauser AE, Hiepe F, Radbruch A, Maintenance of serum antibody levels. Annu Rev Immunol. 2005;23: 367–386. doi: 10.1146/annurev.immunol.23.021704.115723 15771575
15. van der Laan MJ, Polley EC, Hubbard AE, Super learner. Stat Appl Genet Mol Biol. 2007;6: Article25. doi: 10.2202/1544-6115.1309 17910531
16. Steel C, Kubofcik J, Ottesen EA, Nutman TB, Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA). PLoS Negl Trop Dis. 2012;6: e1940. doi: 10.1371/journal.pntd.0001940 23236533
17. Kubofcik J, Fink DL, Nutman TB, Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis. 2012;6: e1930. doi: 10.1371/journal.pntd.0001930 23236529
18. Molineaux L, Gramiccia G, The Garki Project [Internet]. World Health Organization; 1980. http://garkiproject.nd.edu/static/documents/garkiproject.pdf
19. Hamlin KL, Moss DM, Priest JW, Roberts J, Kubofcik J, Gass K, et al. Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti. PLoS Negl Trop Dis. 2012;6: e1941. doi: 10.1371/journal.pntd.0001941 23236534
20. Moss DM, Montgomery JM, Newland SV, Priest JW, Lammie PJ, Detection of cryptosporidium antibodies in sera and oral fluids using multiplex bead assay. J Parasitol. 2004;90: 397–404. doi: 10.1645/GE-3267 15165066
21. Priest JW, Moss DM, Visvesvara GS, Jones CC, Li A, Isaac-Renton JL, Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin Vaccine Immunol. 2010;17: 1695–1707. doi: 10.1128/CVI.00160-10 20876825
22. Houpt E, Barroso L, Lockhart L, Wright R, Cramer C, Lyerly D, et al. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine. 2004;22: 611–617. 14741152
23. Moss DM, Priest JW, Hamlin K, Derado G, Herbein J, Petri WA, Jret al. Longitudinal evaluation of enteric protozoa in Haitian children by stool exam and multiplex serologic assay. Am J Trop Med Hyg. 2014;90: 653–660. doi: 10.4269/ajtmh.13-0545 24591430
24. Flores J, DuPont HL, Jiang Z-D, Belkind-Gerson J, Mohamed JA, Carlin LG, et al. Enterotoxigenic Escherichia coli Heat-Labile Toxin Seroconversion in US Travelers to Mexico. J Travel Med. Wiley Online Library; 2008;15: 156–161.
25. Strid MA, Dalby T, Mølbak K, Krogfelt KA, Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay. Clin Vaccine Immunol. 2007;14: 741–747. doi: 10.1128/CVI.00192-06 17329442
26. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J, Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis. 2011;17: 1389–1395. doi: 10.3201/eid1708.101837 21801614
27. Jiang X, Wang M, Graham DY, Estes MK, Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992;66: 6527–6532. 1328679
28. McDonald AC, Mac Kenzie WR, Addiss DG, Gradus MS, Linke G, Zembrowski E, et al. Cryptosporidium parvum-specific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J Infect Dis. 2001;183: 1373–1379. doi: 10.1086/319862 11294669
29. Guideline on the Investigation of Bioequivalence [Internet]. European Medicines Agency; 2010. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf
30. van der Laan MJ, Rose S, Targeted Learning: Causal Inference for Observational and Experimental Data. Springer Series in Statistics; 2011.
31. Schuler MS, Rose S, Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies. Am J Epidemiol. 2017;185: 65–73. doi: 10.1093/aje/kww165 27941068
32. Steel C, Golden A, Kubofcik J, LaRue N, de Los Santos T, Domingo GJ, et al. Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. Clin Vaccine Immunol. 2013;20: 1155–1161. doi: 10.1128/CVI.00252-13 23740923
33. Wu L, van den Hoogen LL, Slater H, Walker PGT, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528: S86–93. doi: 10.1038/nature16039 26633770
34. Benaglia T, Chauveau D, Hunter D, Young D, mixtools: An R package for analyzing finite mixture models. J Stat Softw. 2009;32: 1–29.
35. Kerkhof K, Sluydts V, Heng S, Kim S, Pareyn M, Willen L, et al. Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia. Malar J. 2016;15: 510. doi: 10.1186/s12936-016-1558-1 27756395
36. Fedorov V, Mannino F, Zhang R, Consequences of dichotomization. Pharm Stat. John Wiley & Sons, Ltd.; 2009;8: 50–61.
37. Priest JW, Jenks MH, Moss DM, Mao B, Buth S, Wannemuehler K, et al. Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15–39 Years of Age in Cambodia. PLoS Negl Trop Dis. 2016;10: e0004699. doi: 10.1371/journal.pntd.0004699 27136913
38. Gruber S, van der Laan M, tmle: An R Package for Targeted Maximum Likelihood Estimation. J Stat Softw. 2012;51: 1–35.
39. Foreman KJ, Lozano R, Lopez AD, Murray CJ, Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10: 1. doi: 10.1186/1478-7954-10-1 22226226
40. Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ, Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2015;3: 42–52. doi: 10.1016/S2213-2600(14)70239-5 25466337
41. Helb DA, Tetteh KKA, Felgner PL, Skinner J, Hubbard A, Arinaitwe E, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A. 2015;112: E4438–47. doi: 10.1073/pnas.1501705112 26216993
42. Simonsen J, Mølbak K, Falkenhorst G, Krogfelt KA, Linneberg A, Teunis PFM, Estimation of incidences of infectious diseases based on antibody measurements. Stat Med. 2009;28: 1882–1895. doi: 10.1002/sim.3592 19387977
43. Teunis PFM, van Eijkeren JCH, Ang CW, van Duynhoven YTHP, Simonsen JB, Strid MA, et al. Biomarker dynamics: estimating infection rates from serological data. Stat Med. 2012;31: 2240–2248. doi: 10.1002/sim.5322 22419564
44. Sepúlveda N, Stresman G, White MT, Drakeley CJ, Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication. Journal of Immunology Research. Hindawi Publishing Corporation; 2015;2015. http://www.hindawi.com/journals/jir/2015/738030/abs/
45. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005;102: 5108–5113. doi: 10.1073/pnas.0408725102 15792998
46. Akpogheneta OJ, Duah NO, Tetteh KKA, Dunyo S, Lanar DE, Pinder M, et al. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun. 2008;76: 1748–1755. doi: 10.1128/IAI.01333-07 18212081
47. Siegrist C-A, Aspinall R, B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9: 185–194. doi: 10.1038/nri2508 19240757
48. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382: 209–222. doi: 10.1016/S0140-6736(13)60844-2 23680352
49. Korpe PS, Liu Y, Siddique A, Kabir M, Ralston K, Ma JZ, et al. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin Infect Dis. Oxford University Press; 2013;56: 988–992.
50. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL, Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis. 1996;173: 232–236. 8537664
51. Metcalf CJE, Farrar J, Cutts FT, Basta NE, Graham AL, Lessler J, et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet. 2016;388: 728–730. doi: 10.1016/S0140-6736(16)30164-7 27059886
52. Griffin SM, Chen IM, Fout GS, Wade TJ, Egorov AI, Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J Immunol Methods. 2011;364: 83–93. doi: 10.1016/j.jim.2010.11.005 21093445
53. Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis. 2012;6: e1873. doi: 10.1371/journal.pntd.0001873 23133684
54. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. europepmc.org; 1989;40: 418–427. 2540664
55. Poirier MJP, Moss DM, Feeser KR, Streit TG, Chang G-JJ, Whitney M, et al. Measuring Haitian children’s exposure to chikungunya, dengue and malaria. Bull World Health Organ. 2016;94: 817–825A. doi: 10.2471/BLT.16.173252 27821884